On International Women’s Day, it’s tempting to post a message of support on your business socials quickly. Instead, why not consider more effective, longer-term action?

For women building businesses today, that work is often less about visibility and more about sustainability. It is about how we build, how we take risks and how we define success on our own terms. Much of the startup ecosystem still celebrates urgency. Move fast. Scale quickly. Raise early. Go all in. That narrative can be powerful but it is not universal, and it is not always the best option. Article written for Startups Magazine by Judit Mora, CEO of Nuumad

Health tech doesn’t need more code - it needs more empathy. At Nuumad, we’re using human centred design to turn fragmented pharmacy services into meaningful, continuous care.

Startup culture often celebrates speed, risk and all-in commitment. But in complex, regulated sectors, moving fast can be a liability rather than an advantage. Building gradually, alongside other work, can create better decisions, stronger trust and more sustainable growth. Slow beginnings, done with intent, often scale further.

As funding pressures on the NHS intensify, community pharmacies face a defining moment. Today, they must evolve through intelligent technology or risk obsolescence. The good news is that the tools to evolve are here and already operational. Artificial intelligence (AI) isn’t the existential threat some believe, it’s one of several technologies helping drive greater innovation, scalability, and resilience in pharmacy.

I spent my early career at some of London’s biggest healthcare agencies such as Langland, McCann, and Havas, helping brands communicate their value and connect with people. At Langland, I became a digital project manager and started working in UX with a larger technology team. I quickly realised my value wasn’t in speaking their language fluently, but in translating between worlds, connecting user empathy with technical precision. Listening became less about learning jargon and more about spotting patterns others missed. 

Independent pharmacies can mistakenly buy digital tools the same way they buy stock - price first, everything else later. Yet purchasing the wrong digital platform can lock in hidden costs for years. Borrow these six tried-and-tested checks from larger corporates to make a safer, faster decision. 

Independent pharmacies can mistakenly buy digital tools the same way they buy stock - price first, everything else later. Yet purchasing the wrong digital platform can lock in hidden costs for years. Borrow these six tried-and-tested checks from larger corporates to make a safer, faster decision.